Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. S-3 Offering Registration Statement
  2. 424B3 Offering Prospectus
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. UPLOAD Other SEC-generated Letter
  5. S-3 Offering Registration Statement
  6. 424B5 Offering Prospectus
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. S-3 Offering Registration Statement
  10. 424B5 Offering Prospectus
  11. 424B5 Offering Prospectus
  12. 424B5 Offering Prospectus
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. UPLOAD Other SEC-generated Letter
  15. S-3 Offering Registration Statement
  16. 424B4 Offering Prospectus
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. S-1/A Offering Registration Statement

Page 1 of 2 · 26 filings